Original language | English |
---|---|
Pages (from-to) | 193-194 |
Number of pages | 2 |
Journal | Psychotherapy and Psychosomatics |
Volume | 87 |
Issue number | 4 |
DOIs | |
State | Published - Aug 1 2018 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Psychotherapy and Psychosomatics, Vol. 87, No. 4, 01.08.2018, p. 193-194.
Research output: Contribution to journal › Editorial
TY - JOUR
T1 - International task force on benzodiazepines
AU - Balon, Richard
AU - Chouinard, Guy
AU - Cosci, Fiammetta
AU - Dubovsky, Steven L.
AU - Fava, Giovanni A.
AU - Freire, Rafael C.
AU - Greenblatt, David J.
AU - Krystal, John H.
AU - Nardi, Antonio E.
AU - Rickels, Karl
AU - Roth, Thomas
AU - Salzman, Carl
AU - Shader, Richard
AU - Silberman, Edward K.
AU - Sonino, Nicoletta
AU - Starcevic, Vladan
AU - Weintraub, Steven J.
N1 - Funding Information: Dr. Krystal reports the following support. Sources of research support: Department of Veterans Affairs, VA National Center for PTSD; Department of Veterans Affairs/Department of Defense, Consortium for Alleviation of PTSD; National Center for Advancing Translational Science, NIH; National Institute on Alcohol Abuse and Alcoholism, P50 (CTNA); National Institute of Mental Health, FAST-Psychosis Consortium. Paid editorial relationship: Biological Psychiatry (editor). Scientific advisory boards: biOasis Technologies Inc., Biohaven Pharmaceuticals; Blackthorn Therapeutics Inc.; Broad Institute at MIT and Harvard; Lohocla Research Corporation; Luc Therapeutics Inc.; Pfizer Pharmaceuticals; TRImaran Pharma. Stocks: ArNETT Neuroscience Inc.; Bio-haven Medical Sciences; Blackthorn Therapeutics Inc.; Spring Care Inc. Stock options: Biohaven Pharmaceuticals Medical Sciences; Luc Therapeutics Inc. Consulting relationships: AstraZen-eca Pharmaceuticals; Biogen, Idec, MA; Biomedisyn Corporation; Janssen Research & Development; L.E.K. Consulting; Otsuka America Pharmaceuticals Inc.; Pragma Therapeutics; S K Life Science; Spring Care Inc.; Sunovion Pharmaceuticals Inc.; Takeda Industries; Taisho Pharmaceuticals Co. Ltd; Teva Branded Pharmaceutical Products R&D Inc. Patents: Dopamine and Noradrenergic Reuptake Inhibitors in Treatment of Schizophrenia; Glutamate Modulating Agents in the Treatment of Mental Disorders; Intranasal Administration of Ketamine to Treat Depression; Methods of Treating Suicidal Ideation. Provisional patents: Composition and Method to Treat Addiction; Treatment Selection for Major Depressive Disorder; Compounds Compositions and Methods for Treating or Preventing Depression and Other Diseases. Speaker’s Bureau: None.
PY - 2018/8/1
Y1 - 2018/8/1
UR - http://www.scopus.com/inward/record.url?scp=85047429588&partnerID=8YFLogxK
U2 - 10.1159/000489538
DO - 10.1159/000489538
M3 - Editorial
C2 - 29788029
AN - SCOPUS:85047429588
SN - 0033-3190
VL - 87
SP - 193
EP - 194
JO - Psychotherapy and Psychosomatics
JF - Psychotherapy and Psychosomatics
IS - 4
ER -